Tuvirumab
| Monoclonal antibody | |
|---|---|
| Type | ? |
| Source | Human |
| Target | hepatitis B virus |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| (verify) | |
Tuvirumab is a human monoclonal antibody for the treatment of patients with chronic hepatitis B. It has undergone Phase I clinical trials in 2001.